Home > Products > CD20 & CD28
> Recombinant Anti-CD20 x Anti-CD28 Bispecific Antibody (scIgG)
Recombinant Anti-CD20 x Anti-CD28 Bispecific Antibody (scIgG) (CAT#: SCIGG-050)
Recombinant Anti-CD20 x Anti-CD28 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD20 and anti-CD28 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can retarget T cells to tumor cells. It is designed for the research of Lymphoma therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD20 x Anti-CD28 Bispecific Antibody (scIgG) (SCIGG-050). Click the button below to contact us or submit your feedback about this product.